Biological Evaluation of a Fluorescent-Imaging Agent for Medullary Thyroid Cancer in an Orthotopic Model

CONTEXT: The primary and definitive treatment of medullary thyroid cancer (MTC) is surgical resection. Recurrent or residual disease is typically a result of incomplete surgical removal. OBJECTIVE: Our objective is to develop a compound that assists in intraoperative visualization of cancer, which w...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Endocrinol Metab
Autors principals: Rossfeld, Kara K., Justiniano, Steven E., Ding, Haiming, Gong, Li, Kothandaraman, Shankaran, Sawant, Dwitiya, Saji, Motoyasu, Wright, Chadwick L., Kirschner, Lawrence S., Ringel, Matthew D., Tweedle, Michael F., Phay, John E.
Format: Artigo
Idioma:Inglês
Publicat: Endocrine Society 2017
Matèries:
Clinical Research Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5587064/
https://ncbi.nlm.nih.gov/pubmed/28591772
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2017-00573
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars